Predictors for prehypertension in patients with impaired glucose tolerance

Hypertension Research

Volumn 31, Issue 10, 2008, Pages 1913-1920

  Anan, Futoshi ^a,b   Masaki, Takayuki ^b   Ono, Eri ^a   Eto, Takeshi ^a   Iwao, Tetsu ^a   Eshima, Nobuoki ^b   Saikawa, Tetsunori ^b   Yoshimatsu, Hironobu ^b  

^a OITA RED CROSS HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOREACTIVE INSULIN; INSULIN; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HOMEOSTASIS MODEL ASSESSMENT INDEX; HUMAN; HYPERINSULINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PREHYPERTENSION; BLOOD; BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; EARLY DIAGNOSIS; ECHOGRAPHY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEART LEFT VENTRICLE HYPERTROPHY; HYPERINSULINISM; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; RISK FACTOR;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 58149400643     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1913     Document Type: Article

References (36)

1. Burt VL, Whelton P, Roccella EJ, et al: Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey 1988-1991. Hypertension 1995; 25 305-313.
2. Palmer A, Bulpitt C, Beevers G, et al: Risk factors for ischemic heart disease and stroke mortality in young and old hypertensive patients. J Hum Hypertens 1995; 9: 695-697.
3. Ishikawa A, Shibano Y, Asai Y, et al: Blood pressure categories and cardiovascular risk factors in Japan: The Jichi Medical School (JMS) Cohort Study. Hypertens Res 2007; 30: 643-649.
4. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
5. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D: Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet 2001; 358: 1682-1686.
6. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
7. Tsai PS, Ke TL, Huang CJ, et al: Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005; 23: 1355-1360.
8. Anan F, Yonemochi H, Masaki T, et al: High-density lipoprotein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension. Hypertens Res 2007; 30: 125-131.
9. Shinzato T, Ohya Y, Nakamoto M, et al: Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats. Hypertens Res 2007; 30: 863-873.
10. DeFronzo RA, FArrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14 173-194.
11. Salonen JT, Lakka JA, Lakka HM, Valkonen VP, Everson SA, Kaplan GA: Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle aged men. Diabetes 1998; 47: 270-275.
12. Stolar MW: AtheroscleroTis in diabetes: the role of hyperinsulinemia. Metabolism 1988; 37: 1-9.
13. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L: Visceral adiposity and risk of type 2 diabetes: A prospective study among Japanese Americans. Diabetes Care 2000; 23: 465-471.
14. DECODE Study Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnosis criteria. Arch Intern Med 2001; 161: 397-404.
15. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not in impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. Alberti KG, Zimmet P, Shaw J: Metabolic syndrome - a new worldwide definition: A consensus statements from the International Diabetes Federation. Diabetic Med 2006; 23: 469-480.
19. Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
20. Wang Y, Wang QJ: The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines: New challenges of the old problem. Arch Intern Med 2004; 164: 2126-2134.
21. Hsia J, Margolis KL, Eaton CB, et al, Women's Health Initiative Investigators: Prehypertension and cardiovascular disease risk in the women's healthy initiative. Circulation 2007; 115: 855-860.
22. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stem MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-722.
23. Isomaa B, Almgren P, Tuomi T, et al: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
24. Cordero A, Laclaustra M, Leon M, et al: Prehypertension is associated with insulin resistance stste and not with an initial renal function impairement. Am J Hypertens 2006; 19: 189-196.
25. Kanauchi M, Kanauchi K, Hashimoto T, Saito Y: Metabolic syndrome and new category pre-hypertension in a Japanese population. Current Med Res Opin 2004; 20: 1365-1370.
26. Zhang Y, Lee ET, Devereux RB, et al: Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: The Strong Heart Study. Hypertension 2006; 47: 410-414.
27. Christ M, Klima T, Maisch B: Artarial hypertension and metabolic syndrome. Herz 2003; 28: 674-685.
28. Saad MF, Rewers M, Selby J, et al: Insulin resistance and hypertension: The Insulin Resistance Atherosclerosis study. Hypertension 2004; 42: 1324-1331.
29. Sowers JR, Standley PR, Ram JL, Jacober S, Simpson L, Rose K: Hyperinsulinemia, insulin resistance, and hyperglycemia: Contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 1993; 6: S260-S270.
30. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD: Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601-2610.
31. Anan F, Takahashi N, Ooie T, Yufu K, Saikawa T, Yoshimatsu H: Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003; 26: 669-676.
32. Anan F, Yonemochi H, Masaki T, et al: High-density lipo-protein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension. Hypertens Res 2007; 30: 125-131.
33. Scherrer U, Sartori C: Insulin as vascular and sympathoexcitatory hormone: Implication for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96: 4104-4113.
34. Rocchini AP, Katch V, Kveselis D, et al: Insulin and renal sodium retention in obese adolescents. Hypertension 1989; 14: 367-374.
35. Hsueh WA, Law RE: Insulin signaling in the arterial wall. Am J Hypertens 1999; 84: 21J-24J.
36. Ito H, Hiroe M, Hirata Y, et al: Insulin-like growth factor-1 induces cardiac hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993; 87: 1715-1721.